Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis.
作者:
主题词
老年人(Aged);抗肿瘤药(Antineoplastic Agents);癌, 肾细胞(Carcinoma, Renal Cell);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);吲唑类(Indazoles);吲哚类(Indoles);肾肿瘤(Kidney Neoplasms);肺肿瘤(Lung Neoplasms);淋巴转移(Lymphatic Metastasis);男(雄)性(Male);中年人(Middle Aged);分子靶向治疗(Molecular Targeted Therapy);烟酰胺(Niacinamide);苯脲化合物(Phenylurea Compounds);嘧啶类(Pyrimidines);吡咯类(Pyrroles);受体, 血管内皮生长因子(Receptors, Vascular Endothelial Growth Factor);登记(Registries);磺胺类(Sulfonamides);存活率(Survival Rate);治疗结果(Treatment Outcome);停止治疗(Withholding Treatment)
DOI
10.1016/j.eururo.2015.12.031
PMID
26746623
发布时间
2022-03-17
- 浏览21

European urology
469-75页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文